Subscribe
dna-1
vitstudio / shutterstock.com
17 January 2017Biotechnology

Horizon Discovery expands CRISPR licence

UK-based Horizon Discovery has broadened its gene editing capabilities through the amendment of a pre-existing licence with ERS Genomics to include the full commercial rights for the use of CRISPR.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Horizon partners with big pharma company on CRISPR
29 August 2018   UK-based Horizon Discovery has entered into a CRISPR collaboration with an unnamed big pharma company.
Europe
Horizon Discovery expands CRISPR licence with ERS Genomics
5 December 2017   UK-based genomics company Horizon Discovery has expanded its licence coverage for use of the CRISPR gene-editing technology.


Editor's picks

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

Editor's picks

Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Big Pharma
Horizon partners with big pharma company on CRISPR
29 August 2018   UK-based Horizon Discovery has entered into a CRISPR collaboration with an unnamed big pharma company.
Europe
Horizon Discovery expands CRISPR licence with ERS Genomics
5 December 2017   UK-based genomics company Horizon Discovery has expanded its licence coverage for use of the CRISPR gene-editing technology.

More on this story

Big Pharma
Horizon partners with big pharma company on CRISPR
29 August 2018   UK-based Horizon Discovery has entered into a CRISPR collaboration with an unnamed big pharma company.
Europe
Horizon Discovery expands CRISPR licence with ERS Genomics
5 December 2017   UK-based genomics company Horizon Discovery has expanded its licence coverage for use of the CRISPR gene-editing technology.

More features

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims